US Patent Issued to BEIJING JIAOTONG UNIVERSITY, BEIJING ZHIFEI LVZHU BIOPHARMACEUTICAL on Nov. 18 for "Combined vaccine against human respiratory syncytial virus (RSV) infections and method thereof for inducing immune response" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,243, issued on Nov. 18, was assigned to BEIJING JIAOTONG UNIVERSITY (Beijing) and BEIJING ZHIFEI LVZHU BIOPHARMACEUTICAL Co. LTD. (Beijing).

"Combined vaccine against human respiratory syncytial virus (RSV) infections and method thereof for inducing immune response" was invented by Jinsheng He (Beijing), Lin Du (Beijing), Yuanhui Fu (Beijing), Weihua Zhu (Beijing), Xianglei Peng (Beijing), Bo Gao (Beijing), Yanpeng Zheng (Beijing) and Meiqin Liu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a combined vaccine against human respiratory syncytial virus (RSV) infection and a method thereof for inducing immune r...